COMMUNIQUÉS West-GlobeNewswire

-
BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET
22/04/2025 -
BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)
22/04/2025 -
Aveanna to Participate at the Bank of America Securities 2025 Health Care Conference
22/04/2025 -
Best Female Libido Boosters 2025 and Sexual Enhancement Pills for Women - By Oh Yes
22/04/2025 -
MBX Biosciences to Participate in Citizens and RBC May Investor Conferences
22/04/2025 -
InnovAge to Announce Fiscal Third Quarter 2025 Financial Results and Host Conference Call Tuesday, May 6, 2025
22/04/2025 -
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025
22/04/2025 -
March Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of MB-105, First-in-Class CD5 CAR-T Cell Therapy for T-Cell Lymphoma
22/04/2025 -
Invitation to Orion’s Capital Markets Day on 22 May 2025
22/04/2025 -
Mitolyn Reviews (Investigative Warning 2025): A Comprehensive Review of the Revolutionary Mitochondrial and Cellular Health Supplement
22/04/2025 -
Mitolyn Reviews: Ingredients, Benefits, Pros and Cons! Honest Analysis Inside!
22/04/2025 -
Best Supplements for Menopause Weight Gain and Belly Fat 2025 - Top Supplement for Menopausal Weight Loss By YourBiology
22/04/2025 -
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
22/04/2025 -
Telix Reports US$186M Q1 Revenue, Up 62% YOY
22/04/2025 -
Alpha Bites Gummies Reviews (WARNING) Is It Safe for Men’s Health? Understanding Its Natural Ingredients And Benefits!
22/04/2025 -
UPDATE -- AP Biosciences to Present New Preclinical Data at American Association of Cancer Research Annual Meeting
22/04/2025 -
Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the United States over the next five years
22/04/2025 -
Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours
22/04/2025 -
Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
22/04/2025
Pages